Infant Bacterial Therapeutics
IBT | XSTO
Overview
Corporate Details
- ISIN(s):
- SE0008015242 (+3 more)
- LEI:
- 2138008KVBXCRJGP6Z26
- Country:
- Sweden
- Address:
- Bryggargatan 10, 111 21 Stockholm
- Website:
- https://ibtherapeutics.com/
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
IBT is a pharmaceutical company with its registered office in Stockholm with a vision to develop drugs influencing the human infant microbiome, and thereby prevent or treat rare diseases affecting premature infants. IBT is currently developing its lead drug candidate IBP-9414, to prevent NEC and improve feeding tolerance in premature infants. IBP-9414 contains the active compound Lactobacillus reuteri, which is a human bacterial strain naturally present in breast milk. IBT is further pursuing a second rare disease program IBP-1016 for the treatment of an unmet medical need in gastroschisis, a severe disease in infants. By developing these drugs, IBT has the potential to fulfill unmet needs for diseases where there are currently no prevention or treatment therapies available.
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-05-08 17:45 |
Declaration of Voting Results & Voting Rights Announcements
Annual General Meeting of Infant Bacterial Therapeutics
|
English | 41.0 KB | |
| 2025-05-08 17:45 |
Declaration of Voting Results & Voting Rights Announcements
Årsstämma i Infant Bacterial Therapeutics
|
Swedish | 40.6 KB | |
| 2025-05-07 14:30 |
Quarterly Report
|
Swedish | 550.1 KB | |
| 2025-05-07 14:30 |
Quarterly Report
|
English | 549.5 KB | |
| 2025-02-13 08:30 |
Annual Report
|
Swedish | 577.8 KB | |
| 2025-02-13 08:30 |
Annual Report
|
English | 571.2 KB | |
| 2024-08-28 08:30 |
Interim Report
|
Swedish | 578.3 KB | |
| 2024-08-28 08:30 |
Interim Report
|
English | 594.7 KB | |
| 2024-08-15 16:44 |
Regulatory News Service
Infant Bacterial Therapeutics patent godkänt i USA
|
Swedish | 48.9 KB | |
| 2024-08-15 16:44 |
Regulatory News Service
Patent for Infant Bacterial Therapeutics has been approved in the USA
|
English | 48.4 KB | |
| 2024-07-08 16:40 |
Regulatory News Service
“The Connection Study” is completed
|
English | 52.7 KB | |
| 2024-07-08 16:40 |
Regulatory News Service
“The Connection Study” är avslutad
|
Swedish | 53.8 KB | |
| 2024-05-08 18:11 |
Declaration of Voting Results & Voting Rights Announcements
Annual General Meeting of Infant Bacterial Therapeutics
|
English | 44.2 KB | |
| 2024-05-08 18:11 |
Declaration of Voting Results & Voting Rights Announcements
Årsstämma i Infant Bacterial Therapeutics
|
Swedish | 44.0 KB | |
| 2024-05-07 16:00 |
Interim Report
|
Swedish | 573.9 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-11-14 | Maria Ekdahl | Other | Buy | 500 | 17,000.00 SEK |
| 2024-02-08 | Anthon Jahreskog | Other | Buy | 839 | 79,033.80 SEK |
| 2024-02-08 | Anthon Jahreskog | Other | Buy | 161 | 15,134.00 SEK |
| 2023-06-09 | Maria Ekdahl | Other | Buy | 1,086 | 49,956.00 SEK |
| 2023-05-23 | Anders Kronström | Other | Buy | 1,329 | 56,482.50 SEK |
| 2023-05-23 | Anthon Jahreskog | Other | Buy | 851 | 36,593.00 SEK |
| 2023-05-23 | Maria Ekdahl | Other | Buy | 465 | 19,995.00 SEK |
| 2023-05-23 | Anthon Jahreskog | Other | Buy | 149 | 6,377.20 SEK |
| 2023-05-23 | Anthon Jahreskog | Other | Buy | 149 | 6,269.92 SEK |
| 2023-05-22 | Maria Ekdahl | Other | Buy | 709 | 30,487.00 SEK |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
ABIVAX | France | ABVX | |
|
Addex Therapeutics Ltd | Switzerland | ADXN | |
|
AegirBio AB | Sweden | AEGIR | |
|
AGRONOMICS LIMITED | Isle of Man | ANIC | |
|
AIREA PLC | United Kingdom | AIEA | |
|
Alkaloid AD | North Macedonia | ALK | |
| Alma Yesodot Ltd. | Israel | KVSR | ||
|
Antibiotice S.A. | Romania | ATB | |
|
Aran Research & Development (1982) Ltd. | Israel | ARAN | |
|
Asarina Pharma AB | Sweden | ASAP |